Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Before Market Entry
Nov 20 2025
Discover who qualifies for lung cancer screening under new 2023 guidelines. Learn about low-dose CT scans, targeted therapy advances like osimertinib, and how early detection boosts survival rates from 6% to 59%.
Nov 20 2025
May 10 2026
Jan 1 2026
Jan 23 2026
Nov 18 2025